SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001683168-19-003766
Filing Date
2019-11-20
Accepted
2019-11-20 16:00:24
Documents
5
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q AMENDMENT NO. 1 cannapharmarx_10qa1-033119.htm 10-Q/A 333926
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER cannapharmarx_ex3101.htm EX-31.1 9620
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER cannapharmarx_ex3102.htm EX-31.2 9632
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER cannapharmarx_ex3200.htm EX-32 5008
5 GRAPHIC image_001.jpg GRAPHIC 24248
  Complete submission text file 0001683168-19-003766.txt   393025
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

IRS No.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-27055 | Film No.: 191234251
SIC: 2834 Pharmaceutical Preparations